NovoCure Ltd (NVCR)
NASDAQ:NVCR
Holding NVCR?
Track your performance easily

NovoCure (NVCR) Financial Statements

1,382 Followers

NovoCure Financial Overview

NovoCure's market cap is currently ―. The company's EPS TTM is $-1.574; its P/E ratio is -11.44; NovoCure is scheduled to report earnings on October 24, 2024, and the estimated EPS forecast is $-0.33. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 150.36M$ 138.50M$ 133.78M$ 127.32M$ 126.05M
Gross Profit$ 115.70M$ 104.81M$ 101.23M$ 95.23M$ 126.05M
EBIT$ -33.58M$ -41.52M-$ -58.24M$ -62.66M
EBITDA$ -30.72M$ -38.70M-$ -62.13M$ -65.01M
Net Income Common Stockholders$ -33.38M$ -38.76M$ -47.08M$ -49.48M$ -57.42M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 951.19M$ 870.15M$ 910.62M$ 921.25M$ 941.33M
Total Assets$ 1.21B$ 1.12B$ 1.15B$ 1.15B$ 1.16B
Total Debt$ 675.20M$ 595.26M$ 596.24M$ 590.04M$ 587.48M
Net Debt$ -275.99M$ -274.89M$ -314.37M$ -331.21M$ -353.85M
Total Liabilities$ 850.42M$ 762.07M$ 783.63M$ 752.65M$ 743.33M
Stockholders Equity$ 361.75M$ 359.36M$ 362.50M$ 393.70M$ 415.68M
Cash Flow-
Free Cash Flow$ -13.17M$ -43.36M-$ -26.57M$ -29.67M
Operating Cash Flow$ -1.72M$ -31.57M$ -14.56M$ -19.31M$ -22.74M
Investing Cash Flow$ -374.44M$ 246.22M$ 98.50M$ 17.26M$ -13.90M
Financing Cash Flow$ 87.32M$ 213.00K$ 1.91M$ 1.17M$ 7.50M
Currency in USD

NovoCure Earnings and Revenue History

NovoCure Debt to Assets

NovoCure Cash Flow

NovoCure Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis